FibriCheck’s new medical smartwatch app gives smartwatch manufacturers a competitive edge
Tuesday, March 31, 2020 — Hasselt. FibriCheck, the first CE- and FDA-approved medical app, today announces another world premiere: the first smartwatch app that automatically monitors users’ heart rhythms during their sleep. The app, which can be integrated into any brand of smartwatch, detects episodes of both intermittent and silent atrial fibrillation (AF), where symptoms are only felt on and off or not at all, making diagnosis extremely difficult. FibriCheck’s latest innovation offers an easy and effective solution for detecting the most common form of heart rhythm disorder which is responsible for 1 in 4 strokes. As such, it represents a unique opportunity for smartwatch manufacturers to add genuine value to their products in the form of potentially life-saving, built-in technology.